Medical Cannabis, Inc. Subsidiary HempMeds ® Mexico Announces June 2020 as the Largest Sales Bookings Month in Company History

SAN DIEGO, July 6, 2020/ PRNewswire/– Medical Marijuana, Inc.( OTC: MJNA) (the “Business”), the first-ever publicly traded marijuana business in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brand names and supply chain, announced today that its subsidiary HempMeds ® Mexico had its largest-ever sales bookings month in the Business’s history in June 2020.

“ Raul Elizalde, who was just promoted from President of Latin American operations to co-CEO of our international operations, has done a significant job growing our sales and operations in Latin America as proven by June’s success,” said Medical Cannabis, Inc. CEO Dr. Stuart Titus “We are fortunate and grateful to have numerous faithful consumers who continue to purchase our high-quality hemp CBD products.”

In addition to the Company’s sales scheduling success in June, its co-CEO Raul Elizalde was invited to speak on Venture’s expert panel entitled “ Marijuana in Mexico: The Dispute and Opportunities for an Emerging Market” where he talked about the legislative procedure required to legislate cannabis in Mexico, the farming and organisation opportunities the market could bring to the country’s economy, and the potential financial and social change that might follow.

” The HempMeds Mexico group has remarkable talent and perseverance– it’s inspiring to witness their success,” stated HempMeds ® co-CEO Raul Elizalde “The marijuana market is durable and this terrific financial upgrade displays that our portfolio of business is well-positioned for continued development despite the lots of difficulties the world is dealing with today.”

Accomplishments also consist of the Company acquiring favorable news coverage in several nationwide and international news outlets including El Economista, Hora Cero, Fundacion Loto Rojo and numerous others.

About HempMeds ® Mexico
HempMeds ® Mexico is a Mexico-based company that made history by being the first business to get a COFEPRIS federal government import authorization for the cannabis product RSHO-X ™ for a medical indicator. HempMeds ® Mexico prepares to work directly with the Mexican federal government to safely and lawfully supply access to CBD hemp oil items. To learn more, please evaluate the company’s site at http://www.hempmeds.mx

About Medical Cannabis, Inc..
We are a business of firsts ® Medical Marijuana, Inc. ( MJNA) is a marijuana company with three distinct organisation units in the non-psychoactive cannabinoid area: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway ® andHempMeds ®; a pioneer in sourcing the first-rate legal non-psychoactive marijuana products stemmed from industrial hemp; and a cannabinoid-based clinical research study and botanical drug advancement sector led by its pharmaceutical investment companies and partners consisting of AXIM ® Biotechnologies , Inc and Kannalife, Inc Medical Cannabis, Inc. was called a leading CBD producer by CNBC Medical Marijuana, Inc. was also the very first company to get historic import permits for CBD products from the federal governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of global markets. The business’s flagship item Genuine Scientific Hemp Oil has actually been utilized in several successful scientific research studies throughout Mexico and Brazil to comprehend its security and effectiveness.

Medical Marijuana, Inc.’s headquarters is in San Diego, California, and additional info is available at OTCMarkets.com or by checking out www.medicalmarijuanainc.com To see Medical Cannabis, Inc.’s business video, click on this link

Investors and customers are also motivated to buy CBD oil and other items at Medical Cannabis, Inc.’s store.

FORWARD-LOOKING DISCLAIMER

This press release might consist of specific positive declarations and details, as specified within the meaning of Area 27 A of the Securities Act of 1933 and Section 21 E of the Securities Exchange Act of 1934, and goes through the Safe Harbor created by those sections. This material contains statements about expected future events and/or monetary outcomes that are positive in nature and subject to risks and unpredictabilities. Such forward-looking statements by meaning involve risks, unpredictabilities and other factors, which may trigger the actual results, performance or accomplishments of Medical Cannabis, Inc. to be materially different from the declarations made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements have actually not been evaluated by the Fda. This product is not meant to identify, deal with, treat, or avoid any illness.

LEGAL DISCLOSURE

Medical Marijuana, Inc. does not offer or distribute any items that remain in violation of the United States Controlled Substances Act.

CONTACT:

Public Relations Contact:

Andrew Hard

Ceo

CMW Media

P. 858-264-6600

[email protected]

www.cmwmedia.com